Keywords: swiss, approve, ares-serono, rebif, switzerland, intercantonal, office

Swiss approve Ares-Serono's Rebif

Article | 21 January 1999

- Switzerland's Intercantonal Office for the Control of Medicineshas approved Ares-Serono's Rebif (recombinant interferon beta-1a) for the treatment of relapsing-remitting ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Interferon beta-1a

Rebif

Antihemophilic Factor

Recombinant

Avonex

Go to drug listing